Skip to main content

TodayDiscoverDiscover ScreenerResearchOwnPortfolio

Discover

U.S. session

Not investment adviceRead full disclaimer

Today Discover Screener Portfolio

GLP-1 & obesity stocks: what's driving them | finqOS

Discover›Theme

Updated 2:30 PM ET

GLP-1 & obesity

GLP-1 drugs treat diabetes and obesity; these companies make, develop or sell them.

These 6 stocks, equal weightS&P 500

These 6 stocks: +13.0%
S&P 500: +4.4%

The 6 stocks

CompanyWhy it’s inPriceToday

Makes Mounjaro and Zepbound, GLP-1 drugs for diabetes and weight Theme
$1,416.81+0.41%
Makes Ozempic and Wegovy, GLP-1 drugs for diabetes and weight Theme
$40.24−0.53%
Large drugmaker developing obesity drugs, including MariTide Theme
$462.39−0.66%
Develops obesity drugs in clinical trials Theme
$26.30−1.98%
Telehealth company that sells weight-loss treatments Theme
$25.42+0.73%
Large drugmaker developing obesity treatments Theme
$30.29−1.24%

Evidence is being prepared